RNA interference: From gene silencing to gene-specific therapeutics

Akaneya, 2005, RNAi-induced gene silencing by local electroporation in targeting brain region, J Neurophysiol, 93, 594, 10.1152/jn.00161.2004 Alberi, 2004, Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons, Development, 131, 3229, 10.1242/dev.01128 Allerson, 2005, Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA, J Med Chem, 48, 901, 10.1021/jm049167j Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, 3, 917, 10.1038/nm0897-917 Archacki, 2004, Expression profiling of cardiovascular disease, Hum Genomics, 1, 355, 10.1186/1479-7364-1-5-355 Arts, 2003, Adenoviral vectors expressing SiRNAs for discovery and validation of gene function, Genome Res, 13, 2325, 10.1101/gr.1332603 Aza-Blanc, 2003, Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening, Mol Cell, 12, 627, 10.1016/S1097-2765(03)00348-4 Aznar, 2004, Rho GTPases: potential candidates or anticancer therapy, Cancer Lett, 206, 181, 10.1016/j.canlet.2003.08.035 Ball, 2003, Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma, Am J Pharmacogenomics, 3, 97, 10.2165/00129785-200303020-00003 Banerjea, 2003, Inhibition of HIV-1 by lentiviral vector-transduced SiRNAs in T lymphocytes differentiated in SCID-Hu mice and CD34+ progenitor cell-derived macrophages, Mol Ther, 8, 62, 10.1016/S1525-0016(03)00140-0 Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Berns, 2004, A large-scale RNAi screen in human cells identifies new components of he p53 pathway, Nature, 428, 431, 10.1038/nature02371 Bernstein, 2001, Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature, 409, 363, 10.1038/35053110 Bertrand, 2002, Comparison of antisense oligonucleotides and SiRNAs in cell culture and in vivo, Biochem Biophys Res Commun, 296, 1000, 10.1016/S0006-291X(02)02013-2 Blobe, 2000, Role of transforming growth factor beta in human disease, N Engl J Med, 342, 1350, 10.1056/NEJM200005043421807 Boden, 2004, Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors, Mol Ther, 9, 396, 10.1016/j.ymthe.2003.11.025 Braasch, 2003, RNA interference in mammalian cells by chemically-modified RNA, Biochemistry, 42, 7967, 10.1021/bi0343774 Braasch, 2004, Biodistribution of phosphodiester and phosphorothioate SiRNA, Bioorg Med Chem Lett, 14, 1139, 10.1016/j.bmcl.2003.12.074 Brazas, 2005, Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid? Polymer-based transfection reagents, Methods Enzymol, 392, 112, 10.1016/S0076-6879(04)92007-1 Breaker, 2004, Natural and engineered nucleic acids as tools to explore biology, Nature, 432, 838, 10.1038/nature03195 Bridge, 2003, Induction of an interferon response by RNAi vectors in mammalian cells, Nat Genet, 34, 263, 10.1038/ng1173 Brummelkamp, 2002, Stable suppression of tumorigenicity by virus-mediated RNA interference, Cancer Cell, 2, 243, 10.1016/S1535-6108(02)00122-8 Buckingham, 2004, RNA interference: from model organisms towards therapy for neural and neuromuscular disorders, Hum Mol Genet, 13, R275, 10.1093/hmg/ddh224 Butz, 2003, SiRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells, Oncogene, 22, 5938, 10.1038/sj.onc.1206894 Caplen, 2001, Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems, Proc Natl Acad Sci U S A, 98, 9742, 10.1073/pnas.171251798 Carpenter, 2004, Systematic genome-wide screens of gene function, Nat Rev Genet, 5, 11, 10.1038/nrg1248 Caudy, 2003, A micrococcal nuclease homologue in RNAi effector complexes, Nature, 425, 411, 10.1038/nature01956 Chang, 2004, Using SiRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown, Am J Pathol, 165, 1535, 10.1016/S0002-9440(10)63411-6 Chen, 2002, CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells, Dev Cell, 3, 339, 10.1016/S1534-5807(02)00258-7 Chen, 2004, Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin, J Clin Invest, 113, 1784, 10.1172/JCI200420673 Chi, 2003, Genomewide view of gene silencing by small interfering RNAs, Proc Natl Acad Sci U S A, 100, 6343, 10.1073/pnas.1037853100 Chow, 2004, The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer, Mol Cancer Ther, 3, 911 Cookson, 2004, The immunogenetics of asthma and eczema: a new focus on the epithelium, Nat Rev Immunol, 4, 978, 10.1038/nri1500 Couzin, 2002, Breakthrough of the year. Small RNAs make big splash, Science, 298, 2296, 10.1126/science.298.5602.2296 Couzin, 2004, Molecular biology. RNAi shows cracks in its armor, Science, 306, 1124, 10.1126/science.306.5699.1124 Crooke, 2004, Progress in antisense technology, Annu Rev Med, 55, 61, 10.1146/annurev.med.55.091902.104408 Dasgupta, 2004, Using RNAi to catch Drosophila genes in a web of interactions: insights into cancer research, Oncogene, 23, 8359, 10.1038/sj.onc.1208028 Dave, 2004, Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains, J Virol, 78, 13687, 10.1128/JVI.78.24.13687-13696.2004 Debes, 2002, P300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6, Cancer Res, 62, 5632 DeFilippis, 2003, Functional genomics in virology and antiviral drug discovery, Trends Biotechnol, 21, 452, 10.1016/S0167-7799(03)00207-5 Deininger, 2004, The development of imatinib as a therapeutic agent for chronic myeloid leukemia, Blood, 105, 2640, 10.1182/blood-2004-08-3097 Dillon, 2004, RNAi as an experimental and therapeutic tool to study and regulate physiological and disease processes, Annu Rev Physiol, 67, 147, 10.1146/annurev.physiol.67.040403.130716 Doench, 2003, SiRNAs can function as MIRNAS, Genes Dev, 17, 438, 10.1101/gad.1064703 Drews, 2000, Drug discovery: a historical perspective, Science, 287, 1960, 10.1126/science.287.5460.1960 Dykxhoorn, 2005, The silent revolution: RNA interference as basic biology, research tool, and therapeutic, Annu Rev Med, 56, 401, 10.1146/annurev.med.56.082103.104606 Dykxhoorn, 2003, Killing the messenger: short RNAs that silence gene expression, Nat Rev Mol Cell Biol, 4, 457, 10.1038/nrm1129 Elbashir, 2001, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 494, 10.1038/35078107 Elmen, 2005, Locked nucleic acid (LNA) mediated improvements in SiRNA stability and functionality, Nucleic Acids Res, 33, 439, 10.1093/nar/gki193 Erfle, 2004, SiRNA cell arrays for high-content screening microscopy, Biotechniques, 37, 454, 10.2144/04373RT01 Finigan, 2005, Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation, J Biol Chem, 280, 17286, 10.1074/jbc.M412427200 Fire, 1998, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 391, 806, 10.1038/35888 Fougerolles, 2005, RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics, Methods Enzymol, 392, 278, 10.1016/S0076-6879(04)92016-2 Freimann, 2004, Drug development for ovarian hyper-stimulation and anti-cancer treatment: blocking of gonadotropin signaling for epiregulin and amphiregulin biosynthesis, Biochem Pharmacol, 68, 989, 10.1016/j.bcp.2004.05.027 Fritsch, 2004, Conditional gene knock-down by cre-dependent short interfering RNAs, EMBO Rep, 5, 178, 10.1038/sj.embor.7400064 Gagnon, 2004, AKT involvement in cisplatin chemoresistance of human uterine cancer cells, Gynecol Oncol, 94, 785, 10.1016/j.ygyno.2004.06.023 Ge, 2004, Use of SiRNAs to prevent and treat influenza virus infection, Virus Res, 102, 37, 10.1016/j.virusres.2004.01.013 Ge, 2004, Inhibition of influenza virus production in virus-infected mice by RNA interference, Proc Natl Acad Sci U S A, 101, 8676, 10.1073/pnas.0402486101 Giladi, 2003, Small interfering RNA inhibits hepatitis B virus replication in mice, Mol Ther, 8, 769, 10.1016/S1525-0016(03)00244-2 Golzio, 2005, Inhibition of gene expression in mice muscle by in vivo electrically mediated SiRNA delivery, Gene Ther, 12, 246, 10.1038/sj.gt.3302405 Gou, 2004, Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo, Nucleic Acids Res, 32, e134, 10.1093/nar/gnh129 Gresch, 2004, New non-viral method for gene transfer into primary cells, Methods, 33, 151, 10.1016/j.ymeth.2003.11.009 Grishok, 2002, RNAi (Nematodes: Caenorhabditis elegans), Adv Genet, 46, 339, 10.1016/S0065-2660(02)46012-9 Gunsalus, 2005, RNAi as a tool to study cell biology: building the genome–phenome bridge, Curr Opin Cell Biol, 17, 3, 10.1016/j.ceb.2004.12.008 Gupta, 2004, Inducible, reversible, and stable RNA interference in mammalian cells, Proc Natl Acad Sci U S A, 101, 1927, 10.1073/pnas.0306111101 Gurujeyalakshmi, 1995, Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression, Exp Lung Res, 21, 791, 10.3109/01902149509050842 Hacein-Bey-Abina, 2003, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science, 302, 415, 10.1126/science.1088547 Hagstrom, 2004, A facile nonviral method for delivering genes and SiRNAs to skeletal muscle of mammalian limbs, Mol Ther, 10, 386, 10.1016/j.ymthe.2004.05.004 Hall, 2004, RNA interference using boranophosphate SiRNAs: structure–activity relationships, Nucleic Acids Res, 32, 5991, 10.1093/nar/gkh936 Hamar, 2004, Small interfering RNA targeting fas protects mice against renal ischemia–reperfusion injury, Proc Natl Acad Sci U S A, 101, 14883, 10.1073/pnas.0406421101 Hamilton, 2002, Two classes of short interfering RNA in RNA silencing, EMBO J, 21, 4671, 10.1093/emboj/cdf464 Harborth, 2003, Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing, Antisense Nucleic Acid Drug Dev, 13, 83, 10.1089/108729003321629638 Hardy, 2004, The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets, Drug Discov Today, 9, 117, 10.1016/S1359-6446(03)02969-6 Hassani, 2004, Lipid-mediated SiRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels, J Gene Med, 7, 198, 10.1002/jgm.659 Hasuwa, 2002, Small interfering RNA and gene silencing in transgenic mice and rats, FEBS Lett, 532, 227, 10.1016/S0014-5793(02)03680-3 Heidel, 2004, Lack of interferon response in animals to naked SiRNAs, Nat Biotechnol, 22, 1579, 10.1038/nbt1038 Hemann, 2003, An Epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo, Nat Genet, 33, 396, 10.1038/ng1091 Hoa, 2003, Characterization of RNA interference in an Anopheles gambiae cell line, Insect Biochem Mol Biol, 33, 949, 10.1016/S0965-1748(03)00101-2 Hoelters, J., Ciccarella, M., Drechsel, M., Geissler, C., Gulkan, H., & Bocker, W., et al. (in press). Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.J Gene Med. Holen, 2003, Similar behaviour of single-strand and double-strand SiRNAs suggests they act through a common RNAi pathway, Nucleic Acids Res, 31, 2401, 10.1093/nar/gkg338 Hommel, 2003, Local gene knockdown in the brain using viral-mediated RNA interference, Nat Med, 9, 1539, 10.1038/nm964 Hopkins, 2002, The druggable genome, Nat Rev Drug Discov, 1, 727, 10.1038/nrd892 Howard, 2003, Unlocking the money-making potential of RNAi, Nat Biotechnol, 21, 1441, 10.1038/nbt1203-1441 Hsieh, 2004, A library of SiRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens, Nucleic Acids Res, 32, 893, 10.1093/nar/gkh238 Huang, 2004, Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference, J Biol Chem, 279, 16657, 10.1074/jbc.C400046200 Huang, 2004, Androgens repress bcl-2 expression via activation of the retinoblastoma (rb) protein in prostate cancer cells, Oncogene, 23, 2161, 10.1038/sj.onc.1207326 Ikeda, 2004, PLZF promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1, J Biol Chem, 280, 8523, 10.1074/jbc.M409442200 Jackson, 2003, Expression profiling reveals off-target gene regulation by RNAi, Nat Biotechnol, 21, 635, 10.1038/nbt831 Jackson, 2004, Noise amidst the silence: off-target effects of SiRNAs?, Trends Genet, 20, 521, 10.1016/j.tig.2004.08.006 Jeffery, 2005, BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways, Am J Physiol Lung Cell Mol Physiol, 288, L370, 10.1152/ajplung.00242.2004 Jiang, 2004, Gel-based application of SiRNA to human epithelial cancer cells induces RNAi-dependent apoptosis, Oligonucleotides, 14, 239, 10.1089/oli.2004.14.239 July, 2004, Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo, Mol Cancer Ther, 3, 223 Kao, 2004, BACE1 suppression by RNA interference in primary cortical neurons, J Biol Chem, 279, 1942, 10.1074/jbc.M309219200 Karasarides, 2004, B-RAF is a therapeutic target in melanoma, Oncogene, 23, 6292, 10.1038/sj.onc.1207785 Kariko, 2004, Exogenous SiRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3, Cells Tissues Organs, 177, 132, 10.1159/000079987 Karlas, 2004, Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation, Virology, 325, 18, 10.1016/j.virol.2004.04.022 Kartasheva, 2002, P53 induces the expression of its antagonist p73 delta N, establishing an autoregulatory feedback loop, Oncogene, 21, 4715, 10.1038/sj.onc.1205584 Kasim, 2004, Control of SiRNA expression using the cre-loxp recombination system, Nucleic Acids Res, 32, e66, 10.1093/nar/gnh061 Khan, 2004, Sustained polymeric delivery of gene silencing antisense ODNs, SiRNA, DNAzymes and ribozymes: in vitro and in vivo studies, J Drug Target, 12, 393, 10.1080/10611860400003858 Kim, 2004, Inhibition of ocular angiogenesis by SiRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis, Am J Pathol, 165, 2177, 10.1016/S0002-9440(10)63267-1 Kim, 2005, Modification of professional antigen-presenting cells with small interfering rna in vivo to enhance cancer vaccine potency, Cancer Res, 65, 309 Kisielow, 2002, Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA, Biochem J, 363, 1, 10.1042/0264-6021:3630001 Kittler, 2004, An endoribonuclease-prepared SiRNA screen in human cells identifies genes essential for cell division, Nature, 432, 1036, 10.1038/nature03159 Krick, 2005, Role of HIF-1{Alpha} in hypoxia-induced apoptosis of primary alveolar epithelial type II cells, Am J Respir Cell Mol Biol, 32, 395, 10.1165/rcmb.2004-0314OC Kumar, 2002, Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference, Malar J, 1, 5, 10.1186/1475-2875-1-5 Kumar, 2003, High-throughput selection of effective RNAi probes for gene silencing, Genome Res, 13, 2333, 10.1101/gr.1575003 Kunath, 2003, Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype, Nat Biotechnol, 21, 559, 10.1038/nbt813 Kuttenkeuler, 2004, Genome-wide RNAi as a route to gene function in Drosophila, Brief Funct Genomic Proteomic, 3, 168, 10.1093/bfgp/3.2.168 Kwak, 2004, Genetically engineered mouse models for lung cancer, Annu Rev Physiol, 66, 647, 10.1146/annurev.physiol.66.032102.134301 Lapteva, 2004, CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo, Cancer Gene Ther, 12, 84, 10.1038/sj.cgt.7700770 Lassus, 2002, Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization, Science, 297, 1352, 10.1126/science.1074721 Layzer, 2004, In vivo activity of nuclease-resistant SiRNAs, RNA, 10, 766, 10.1261/rna.5239604 Lee, 2003, The nuclear RNase III drosha initiates MicroRNA processing, Nature, 425, 415, 10.1038/nature01957 Lettre, 2004, Genome-wide RNAi identifies p53-dependent and -independent regulators of germ cell apoptosis in C Elegans, Cell Death Differ, 11, 1198, 10.1038/sj.cdd.4401488 Lewis, 2005, Delivery of SiRNA and SiRNA expression constructs to adult mammals by hydrodynamic intravascular injection, Methods Enzymol, 392, 336, 10.1016/S0076-6879(04)92020-4 Li, 2003, Inhibition of HIV-1 infection by lentiviral vectors expressing pol III-promoted anti-HIV RNAs, Mol Ther, 8, 196, 10.1016/S1525-0016(03)00165-5 Li, 2004, Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA, Ann Neurol, 56, 124, 10.1002/ana.20141 Lieberman, 2003, Interfering with disease: opportunities and roadblocks to harnessing RNA interference, Trends Mol Med, 9, 397, 10.1016/S1471-4914(03)00143-6 Lipscomb, 2003, Use of RNA interference to inhibit integrin (Alpha6beta4)-mediated invasion and migration of breast carcinoma cells, Clin Exp Metastasis, 20, 569, 10.1023/A:1025819521707 Liu, 1999, Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA, Gene Ther, 6, 1258, 10.1038/sj.gt.3300947 Lomas-Neira, J. L., Chung, C. S., Wesche, D. E., Perl, M., & Ayala, A., (in press). In vivo gene silencing (With SiRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury.J Leukoc Biol. Lorenz, 2004, Steroid and lipid conjugates of SiRNAs to enhance cellular uptake and gene silencing in liver cells, Bioorg Med Chem Lett, 14, 4975, 10.1016/j.bmcl.2004.07.018 Lum, 2003, Identification of hedgehog pathway components by RNAi in Drosophila cultured cells, Science, 299, 2039, 10.1126/science.1081403 Ma, 2004, Specific inhibition of HTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell, Zhonghua Wai Ke Za Zhi, 42, 1372 Malaney, 2004, The Malaria Gap, Am J Trop Med Hyg, 71, 141, 10.4269/ajtmh.2004.71.141 Marshall, 2003, Gene therapy. Second child in french trial is found to have leukemia, Science, 299, 320, 10.1126/science.299.5605.320 Martinez, 2002, Synthetic small Inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore P53 pathways, Proc Natl Acad Sci U S A, 99, 14849, 10.1073/pnas.222406899 Massaro, 2004, Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice, Am J Physiol Lung Cell Mol Physiol, 287, L1066, 10.1152/ajplung.00067.2004 Matsuda, 2004, Electroporation and RNA interference in the rodent retina in vivo and in vitro, Proc Natl Acad Sci U S A, 101, 16, 10.1073/pnas.2235688100 Matsukura, 2003, Establishment of conditional Vectors for hairpin SiRNA knockdowns, Nucleic Acids Res, 31, e77, 10.1093/nar/gng077 McBride, 1999, Pulmonary function changes in children after respiratory syncytial virus infection in infancy, J Pediatr, 135, 28 McCaffrey, 2002, Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice, Mol Ther, 5, 676, 10.1006/mthe.2002.0600 McCown, 2003, The utility of SiRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses, Virology, 313, 514, 10.1016/S0042-6822(03)00341-6 Mello, 2004, Revealing the world of RNA interference, Nature, 431, 338, 10.1038/nature02872 Minakuchi, 2004, Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo, Nucleic Acids Res, 32, e109, 10.1093/nar/gnh093 Mittal, 2004, Improving the efficiency of RNA interference in mammals, Nat Rev Genet, 5, 355, 10.1038/nrg1323 Miyagishi, 2003, Strategies for generation of an SiRNA expression library directed against the human genome, Oligonucleotides, 13, 325, 10.1089/154545703322617005 Monick, 2004, Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis, J Biol Chem, 280, 2147, 10.1074/jbc.M408745200 Muratovska, 2004, Conjugate for efficient delivery of short interfering RNA (SiRNA) into mammalian cells, FEBS Lett, 558, 63, 10.1016/S0014-5793(03)01505-9 Murphy, 2000, Deaths: final data for 1998, Natl Vital Stat Rep, 48, 1 Ning, 2004, SiRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth, Int J Oncol, 25, 1065 Omi, 2004, Long-lasting RNAi activity in mammalian neurons, FEBS Lett, 558, 89, 10.1016/S0014-5793(04)00017-1 Osta, 2004, Effects of mosquito genes on plasmodium development, Science, 303, 2030, 10.1126/science.1091789 Osta, 2004, Innate immunity in the malaria vector Anopheles gambiae: comparative and functional genomics, J Exp Biol, 207, 2551, 10.1242/jeb.01066 Osta, 2004, EpCAM Is overexpressed in breast cancer and is a potential target for breast cancer gene therapy, Cancer Res, 64, 5818, 10.1158/0008-5472.CAN-04-0754 Paddison, 2004, A resource for large-scale RNA-interference-based screens in mammals, Nature, 428, 427, 10.1038/nature02370 Park, 2004, Double-stranded SiRNA targeted to the huntingtin gene does not induce DNA methylation, Biochem Biophys Res Commun, 323, 275, 10.1016/j.bbrc.2004.08.096 Paroo, 2004, Challenges for RNAi in Vivo, Trends Biotechnol, 22, 390, 10.1016/j.tibtech.2004.06.004 Persengiev, 2004, Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (SiRNAs), RNA, 10, 12, 10.1261/rna5160904 Petri, 2002, Pathogenesis of amebiasis, Curr Opin Microbiol, 5, 443, 10.1016/S1369-5274(02)00335-1 Pille, 2005, Anti-RhoA and Anti-RhoC SiRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo, Mol Ther, 11, 267, 10.1016/j.ymthe.2004.08.029 Pistelli, 2003, Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity, Eur Respir J, Suppl 40, 10s, 10.1183/09031936.03.00403403 Poulin, 2004, Genome-wide RNAi screens in Caenorhabditis elegans: impact on cancer research, Oncogene, 23, 8340, 10.1038/sj.onc.1208010 Pusch, 2003, Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA, Nucleic Acids Res, 31, 6444, 10.1093/nar/gkg876 Qin, 2003, Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5, Proc Natl Acad Sci U S A, 100, 183, 10.1073/pnas.232688199 Randall, 2003, Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs, Proc Natl Acad Sci U S A, 100, 235, 10.1073/pnas.0235524100 Randall, 2004, Interfering With hepatitis C virus RNA replication, Virus Res, 102, 19, 10.1016/j.virusres.2004.01.011 Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 Rennard, 1999, Inflammation and repair processes in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 160, S12, 10.1164/ajrccm.160.supplement_1.5 Reynolds, 2004, Rational SiRNA design for RNA interference, Nat Biotechnol, 22, 326, 10.1038/nbt936 Rosahl, 2003, Validation of GABA(A) receptor subtypes as potential drug targets by using genetically modified mice, Curr Drug Targets CNS Neurol Disord, 2, 207, 10.2174/1568007033482823 Rubinson, 2003, A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference, Nat Genet, 33, 401, 10.1038/ng1117 Rudd, 2005, Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression, J Virol, 79, 3350, 10.1128/JVI.79.6.3350-3357.2005 Sacco, 2004, Epithelial cells and fibroblasts: structural repair and remodelling in the airways, Paediatr Respir Rev, 5, S35, 10.1016/S1526-0542(04)90008-5 Saxena, 2003, Small RNAs with imperfect match to endogenous MRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells, J Biol Chem, 278, 44312, 10.1074/jbc.M307089200 Scacheri, 2004, Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells, Proc Natl Acad Sci U S A, 101, 1892, 10.1073/pnas.0308698100 Schiffelers, 2004, Cancer SiRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle, Nucleic Acids Res, 32, e149, 10.1093/nar/gnh140 Schwarz, 2003, Asymmetry in the assembly of the RNAi enzyme complex, Cell, 115, 199, 10.1016/S0092-8674(03)00759-1 Semizarov, 2004, SiRNA-mediated gene silencing: a global genome view, Nucleic Acids Res, 32, 3836, 10.1093/nar/gkh714 Shao, 2004, Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells, Am J Physiol Lung Cell Mol Physiol, 287, L420, 10.1152/ajplung.00019.2004 Shu, 2002, Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases, Mol Cell Biol, 22, 7758, 10.1128/MCB.22.22.7758-7768.2002 Silva, 2004, RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age, Oncogene, 23, 8401, 10.1038/sj.onc.1208176 Siolas, 2005, Synthetic ShRNAs as potent RNAi triggers, Nat Biotechnol, 23, 227, 10.1038/nbt1052 Sioud, 2004, Systemic delivery of synthetic SiRNAs, Methods Mol Biol, 252, 515 Siripurapu, 2005, DBC2 significantly influences cell-cycle, apoptosis cytoskeleton and membrane-trafficking pathways, J Mol Biol, 346, 83, 10.1016/j.jmb.2004.11.043 Sledz, 2003, Activation of the interferon system by short-interfering RNAs, Nat Cell Biol, 5, 834, 10.1038/ncb1038 Snove, 2004, Many commonly used SiRNAs risk off-target activity, Biochem Biophys Res Commun, 319, 256, 10.1016/j.bbrc.2004.04.175 Song, 2003, RNA interference targeting fas protects mice from fulminant hepatitis, Nat Med, 9, 347, 10.1038/nm828 Sorensen, 2003, Gene silencing by systemic delivery of synthetic SiRNAs in adult mice, J Mol Biol, 327, 761, 10.1016/S0022-2836(03)00181-5 Soutschek, 2004, Therapeutic silencing of an endogenous gene by systemic administration of modified SiRNAs, Nature, 432, 173, 10.1038/nature03121 Stege, 2004, Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference, Cancer Gene Ther, 11, 699, 10.1038/sj.cgt.7700751 Sugimoto, 2004, Throughput RNAi in Caenorhabditis elegans: genome-wide screens and functional genomics, Differentiation, 72, 81, 10.1111/j.1432-0436.2004.07202004.x Sun, 2004, The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes, Mol Cell, 14, 289, 10.1016/S1097-2765(04)00236-9 Takabatake, Y., Isaka, Y., Mizui, M., Kawachi, H., Shimizu, F., & Ito, T., et al. (in press). Exploring RNA interference as a therapeutic strategy for renal disease.Gene Ther. Taniyama, 2002, Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle, Gene Ther, 9, 372, 10.1038/sj.gt.3301678 Thakker, 2004, Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference, Proc Natl Acad Sci U S A, 101, 17270, 10.1073/pnas.0406214101 Tijsterman, 2002, The genetics of RNA silencing, Annu Rev Genet, 36, 489, 10.1146/annurev.genet.36.043002.091619 Tiscornia, 2003, A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA, Proc Natl Acad Sci U S A, 100, 1844, 10.1073/pnas.0437912100 Tiscornia, 2004, CRE recombinase-inducible RNA interference mediated by lentiviral vectors, Proc Natl Acad Sci U S A, 101, 7347, 10.1073/pnas.0402107101 Tuschl, 2002, Expanding small RNA interference, Nat Biotechnol, 20, 446, 10.1038/nbt0502-446 Ulanova, 2005, Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells, Am J Physiol Lung Cell Mol Physiol, 288, L497, 10.1152/ajplung.00246.2004 Urban-Klein, 2005, RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed SiRNA in vivo, Gene Ther, 12, 461, 10.1038/sj.gt.3302425 van Haaften, 2004, Genomic instability and cancer: scanning the Caenorhabditis elegans genome for tumor suppressors, Oncogene, 23, 8366, 10.1038/sj.onc.1208011 Vanhecke, 2004, High-throughput gene silencing using cell arrays, Oncogene, 23, 8353, 10.1038/sj.onc.1208027 Vanhecke, 2004, High-throughput gene silencing using cell arrays, Oncogene, 23, 8353, 10.1038/sj.onc.1208027 Vanhecke, 2005, Functional genomics using high-throughput RNA interference, Drug Discov Today, 10, 205, 10.1016/S1359-6446(04)03352-5 Vayssie, 2004, Double-stranded RNA mediates homology-dependant gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica, Mol Biochem Parasitol, 138, 21, 10.1016/j.molbiopara.2004.07.005 Verdrager, 1995, Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum, Southeast Asian J Trop Med Public Health, 26, 23 Verma, 2003, Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells, Clin Cancer Res, 9, 1291 Vernick, 2004, Genomics and malaria control, N Engl J Med, 351, 1901, 10.1056/NEJMcibr042899 Vickers, 2003, Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis, J Biol Chem, 278, 7108, 10.1074/jbc.M210326200 Wall, 2003, Small RNA: can RNA interference be exploited for therapy?, Lancet, 362, 1401, 10.1016/S0140-6736(03)14637-5 Wang, 2005, RNA interference in Caenorhabditis elegans, Methods Enzymol, 392, 36, 10.1016/S0076-6879(04)92003-4 Wang, 2003, RNA interference: antiviral weapon and beyond, World J Gastroenterol, 9, 1657, 10.3748/wjg.v9.i8.1657 Wang, 2004, Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells, J Virol, 78, 7523, 10.1128/JVI.78.14.7523-7527.2004 Wellbrock, 2004, The RAF proteins take centre stage, Nat Rev Mol Cell Biol, 5, 875, 10.1038/nrm1498 Wen, 2004, Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting smads, Am J Respir Cell Mol Biol, 30, 816, 10.1165/rcmb.2002-0249OC Whittaker, 2003, Genes for asthma: much ado about nothing?, Curr Opin Pharmacol, 3, 212, 10.1016/S1471-4892(03)00035-3 Whittaker, 2003, What is the relevance of bioinformatics to pharmacology?, Trends Pharmacol Sci, 24, 434, 10.1016/S0165-6147(03)00197-4 Wilson, 2003, RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells, Proc Natl Acad Sci U S A, 100, 2783, 10.1073/pnas.252758799 Winkler, 2004, Killing the messenger, Nat Rev Drug Discov, 3, 823, 10.1038/nrd1527 Wiznerowicz, 2003, Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference, J Virol, 77, 8957, 10.1128/JVI.77.16.8957-8951.2003 Xia, 2002, SiRNA-mediated gene silencing in vitro and in vivo, Nat Biotechnol, 20, 1006, 10.1038/nbt739 Xia, 2004, RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia, Nat Med, 10, 816, 10.1038/nm1076 Xu, 2005, Reduction of PTP1B by RNAi upregulates the activity of insulin controlled fatty acid synthase promoter, Biochem Biophys Res Commun, 329, 538, 10.1016/j.bbrc.2005.02.016 Yang, 2003, Silencing of H-ras gene expression by retrovirus-mediated SiRNA decreases transformation efficiency and tumor growth in a model of human ovarian cancer, Oncogene, 22, 5694, 10.1038/sj.onc.1206858 Yang, 2005, Inhibition of hepatitis B virus surface antigen expression by small hairpin RNA in vitro, World J Gastroenterol, 11, 498, 10.3748/wjg.v11.i4.498 Yin, 2004, Suppression of Bcl-2 gene by RNA interference increases chemosensitivity to cisplatin in nasopharyngeal carcinoma cell line CNE1, Acta Biochim Biophys Sin (Shanghai), 36, 749, 10.1093/abbs/36.11.749 Yokota, 2004, SiRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme, Biochem Biophys Res Commun, 314, 283, 10.1016/j.bbrc.2003.12.098 Yu, 2002, RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells, Proc Natl Acad Sci U S A, 99, 6047, 10.1073/pnas.092143499 Zaas, 2005, Pseudomonas invasion of type i pneumocytes is dependent on the expression and phosphorylation of caveolin-2, J Biol Chem, 280, 4864, 10.1074/jbc.M411702200 Zambrowicz, 2003, Predicting drug efficacy: knockouts model pipeline drugs of the pharmaceutical industry, Curr Opin Pharmacol, 3, 563, 10.1016/j.coph.2003.04.002 Zender, 2003, Caspase 8 small interfering RNA prevents acute liver failure in mice, Proc Natl Acad Sci U S A, 100, 7797, 10.1073/pnas.1330920100 Zhang, 2002, Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation, Biochim Biophys Acta, 1572, 1, 10.1016/S0304-4165(02)00270-2 Zhang, 2003, Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA, Chin Med J (Engl), 116, 1262 Zhang, 2004, Silencing SARS-CoV spike protein expression in cultured cells by RNA interference, FEBS Lett, 560, 141, 10.1016/S0014-5793(04)00087-0 Zhang, 2004, Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer, Clin Cancer Res, 10, 3667, 10.1158/1078-0432.CCR-03-0740 Zhang, 2005, Inhibition of respiratory syncytial virus infection with intranasal SiRNA nanoparticles targeting the viral NS1 gene, Nat Med, 11, 56, 10.1038/nm1174 Zheng, 2004, An approach to genomewide screens of expressed small interfering RNAs in mammalian cells, Proc Natl Acad Sci U S A, 101, 135, 10.1073/pnas.2136685100 Zhou, 2004, Challenges and strategies: the immune responses in gene therapy, Med Res Rev, 24, 748, 10.1002/med.20009